Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact Dermatitis
Recruiting in Palo Alto (17 mi)
+9 other locations
Age: Any Age
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 4
Waitlist Available
Sponsor: Astellas Pharma Inc
Prior Safety Data
Trial Summary
What is the purpose of this trial?
A study of subjects with a known nickel allergy comparing Tacrolimus to placebo, both associated with nickel patches to determine the safety and efficacy of treating Chronic Allergic Contact Dermatitis with Tacrolimus Ointment
Eligibility Criteria
Inclusion Criteria
Subject has a history of allergy to nickel
Treatment Details
Interventions
- Placebo Ointment (Topical Treatment)
- Tacrolimus Ointment (Calcineurin Inhibitor)
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: 1Experimental Treatment1 Intervention
Group II: 2Placebo Group1 Intervention
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
NCT00667056Hershey, PA
NCT00667056Portland, OR
NCT00667056Lynchburg, VA
NCT00667056New York, NY
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
Astellas Pharma IncLead Sponsor